| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
INIFY Laboratories AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.50 |
| 52 Week High | kr1.04 |
| 52 Week Low | kr0.50 |
| Beta | 0 |
| 1 Month Change | -28.06% |
| 3 Month Change | -40.05% |
| 1 Year Change | -26.47% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -25.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| WY60 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.1% | -0.4% |
| 1Y | -26.5% | -1.3% | 4.2% |
Return vs Industry: WY60 underperformed the German Healthcare industry which returned 2.7% over the past year.
Return vs Market: WY60 underperformed the German Market which returned 5.4% over the past year.
Price Volatility
| WY60 volatility | |
|---|---|
| WY60 Average Weekly Movement | 11.8% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: WY60's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine WY60's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Fredrik Palm | www.inify.com |
INIFY Laboratories AB provides cancer diagnostics services in Sweden. It offers prostate cancer diagnostics services. The company was incorporated in 2021 and is based in Stockholm, Sweden.
INIFY Laboratories AB Fundamentals Summary
| WY60 fundamental statistics | |
|---|---|
| Market cap | €36.81m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs WY60 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WY60 income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
Aug 21, 2024
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did WY60 perform over the long term?
See historical performance and comparison